DK396986D0 - Parenterale phenytoin-praeparater - Google Patents

Parenterale phenytoin-praeparater

Info

Publication number: DK396986D0
Authority: DK; Denmark
Prior art keywords: phenytoin; parenteral; preparations; phenytoin preparations; parenteral phenytoin
Prior art date: 1985-08-21

Application number

DK396986A

Other languages

English (en)

Other versions

DK396986A (da

Inventor

Shui-Hsi Kao

Allen I Kay

Karla Sampson

Original Assignee

Warner Lambert Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-08-21

Filing date

1986-08-20

Publication date

1986-08-20

1986-08-20 Application filed by Warner Lambert Co filed Critical Warner Lambert Co

1986-08-20 Publication of DK396986D0 publication Critical patent/DK396986D0/da

1987-02-22 Publication of DK396986A publication Critical patent/DK396986A/da

Links

CXOFVDLJLONNDW-UHFFFAOYSA-N Phenytoin Chemical compound N1C(=O)NC(=O)C1(C=1C=CC=CC=1)C1=CC=CC=C1 CXOFVDLJLONNDW-UHFFFAOYSA-N 0.000 title 1
229960002036 phenytoin Drugs 0.000 title 1
238000002360 preparation method Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Inorganic Chemistry (AREA)
Neurosurgery (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

DK396986A 1985-08-21 1986-08-20 Parenterale phenytoin-praeparater DK396986A (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US06/767,997 US4696814A (en)	1985-08-21	1985-08-21	Parenteral phenytoin compositions

Publications (2)

Publication Number	Publication Date
DK396986D0 true DK396986D0 (da)	1986-08-20
DK396986A DK396986A (da)	1987-02-22

Family

ID=25081202

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK396986A DK396986A (da)	1985-08-21	1986-08-20	Parenterale phenytoin-praeparater

Country Status (9)

Country	Link
US (1)	US4696814A (da)
EP (1)	EP0212853A3 (da)
JP (1)	JPS6245524A (da)
KR (1)	KR870001832A (da)
AU (1)	AU581319B2 (da)
DK (1)	DK396986A (da)
NZ (1)	NZ217297A (da)
PH (1)	PH22146A (da)
ZA (1)	ZA864300B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8727157D0 (en) *	1987-11-19	1987-12-23	Wellcome Found	Pharmaceutical formulations
AU6001790A (en) *	1989-08-02	1991-02-07	Warner-Lambert Company	Formulations of phenytoin sodium for intravenous administration
IL136051A0 (en) *	1997-11-10	2001-05-20	Sloan Kettering Inst Cancer	Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
AU1917899A (en)	1998-03-20	1999-10-18	Warner-Lambert Company	Crystalline sodium phenytoin monohydrate
US6274168B1 (en)	1999-02-23	2001-08-14	Mylan Pharmaceuticals Inc.	Phenytoin sodium pharmaceutical compositions
WO2004058152A2 (en) *	2002-12-16	2004-07-15	Ranbaxy Pharmaceuticals Inc.	An extended release pharmaceutical composition of phenytoin sodium
US7576216B2 (en)	2004-07-30	2009-08-18	Abbott Laboratories	Preparation of pyridonecarboxylic acid antibacterials
WO2006110815A1 (en) *	2005-04-11	2006-10-19	Abbott Laboratories	Pharmaceutical compositions having improved dissolution profiles for poorly soluble drugs
CA2812968A1 (en) *	2005-12-05	2007-06-14	Taro Pharmaceuticals North America, Inc.	Pharmaceutical formulation containing phenytoin sodium and magnesium stearate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3749779A (en) *	1970-08-27	1973-07-31	American Home Prod	Stable solutions of sodium diphenylhydantoin
IL52533A (en) *	1977-07-15	1980-01-31	Abic Ltd	Injectable chloramphenicol composition
DE3006635A1 (de) *	1980-02-22	1981-08-27	Basf Ag, 6700 Ludwigshafen	Verwendung von mikronisiertem vernetztem, unloeslichem polyvinylpyrrolidon zur stabilisierung von suspensionen

1985
- 1985-08-21 US US06/767,997 patent/US4696814A/en not_active Expired - Fee Related
1986
- 1986-06-06 AU AU58470/86A patent/AU581319B2/en not_active Ceased
- 1986-06-09 ZA ZA864300A patent/ZA864300B/xx unknown
- 1986-07-22 EP EP86305602A patent/EP0212853A3/en not_active Withdrawn
- 1986-08-14 KR KR1019860006690A patent/KR870001832A/ko not_active Ceased
- 1986-08-18 PH PH34156A patent/PH22146A/en unknown
- 1986-08-19 JP JP61192220A patent/JPS6245524A/ja active Pending
- 1986-08-20 NZ NZ217297A patent/NZ217297A/xx unknown
- 1986-08-20 DK DK396986A patent/DK396986A/da not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU581319B2 (en)	1989-02-16
NZ217297A (en)	1988-11-29
US4696814A (en)	1987-09-29
ZA864300B (en)	1987-02-25
PH22146A (en)	1988-06-01
EP0212853A3 (en)	1987-07-29
AU5847086A (en)	1987-03-12
JPS6245524A (ja)	1987-02-27
KR870001832A (ko)	1987-03-28
DK396986A (da)	1987-02-22
EP0212853A2 (en)	1987-03-04

Legal Events

Date	Code	Title	Description
1992-04-21	AHB	Application shelved due to non-payment

Publication	Publication Date	Title
DK100786A (da)	1986-11-21	Parenterale phenytoin-praeparater
DK135086A (da)	1986-09-26	Dielektriske praeparater
NO171977C (no)	1993-05-26	3-aryluracilforbindelser
DK135186A (da)	1986-09-26	Dielektriske praeparater
DK133786D0 (da)	1986-03-21	Praeparater
DK84489A (da)	1989-08-26	Praeparater
DK396986D0 (da)	1986-08-20	Parenterale phenytoin-praeparater
DK24986D0 (da)	1986-01-17	Praeparater
DK401387D0 (da)	1987-07-31	Benzopyranderivatholdige praeparater
ATA131986A (de)	1990-08-15	Eindicker
DK353286A (da)	1987-01-26	Beta-lactamringholdige forbindelser
ATA348785A (de)	1986-12-15	8chaltungsanordnung
DK503386D0 (da)	1986-10-20	Peptidpraeparater
DK466086A (da)	1987-04-09	Exogent syrnede antacidiumpraeparater
DK597885A (da)	1987-06-21	Saccharosefri praeparater
ES284020Y (es)	1986-01-16	Estructura plegable
ES287303Y (es)	1988-04-16	Caja-cesta plegable
RO92655A2 (ro)	1987-09-30	Sampon pentru par
ES291107Y (es)	1986-12-01	Hamaca
RO91968A2 (ro)	1988-05-30	Structura anticondens
KR870009886U (ko)	1987-07-09	서류철구
BR6501202U (pt)	1987-03-31	Cadeira dobravel
KR870009440U (ko)	1987-07-07	절첩 의자
KR860011391U (ko)	1986-10-02	절첩식 의자
BR6501515U (pt)	1987-05-05	Cadeira dobravel